Environmental management in the gut: Fecal transplantation to restore the intestinal ecosystem

Infectious Diseases

Volumn 48, Issue 8, 2016, Pages 593-595

  Young, Vincent B ^a   Hayden, Mary K ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY STRUCTURE; ECOSYSTEM; EDITORIAL; ENVIRONMENTAL MANAGEMENT; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECAL MICROBIOTA TRANSPLANTATION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTESTINE FLORA; INTESTINE FUNCTION; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COMMUNITY; NONHUMAN; MEDICAL RESEARCH;

BIOMEDICAL RESEARCH; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS;

EID: 85009250389     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.1080/23744235.2016.1177200     Document Type: Editorial

References (19)

1. Eloe-Fadrosh EA, Rasko DA. The human micro biome: from symbiosis to pathogenesis. Annu Rev Med. 2013;64:145–163.
2. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13:260–270.
3. Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013;138:1–11.
4. Britton RA, Young VB. Role of the intestinal microbiota in resistanceto colonization by Clostridium difficile. Gastroenterology.2014;146:1547–1553.
5. Rao K, Young VB. Fecal micro biota transplantation for the management of clostridium difficile infection. Infect Dis Clin North Am.2015;29:109–122.
6. Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunction the treatment of pseudo membranous enter colitis. Surgery.1958;44:854–859.
7. Manges AR, Steiner TS, Wright AJ. Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial resistant opportunistic pathogens: a review. Infect Dis (London).2016;48.
8. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med.2013;368:407–415.
9. Halpin AL, de Man TJ, Kraft CS, et al. Intestinal micro biome disruption in patients in a long-term acute care hospital: a case for development of micro biome disruption indices to improve infection prevention. Am J Infect Control. 2016. [Epub ahead of print]. DOI: 10.1016/j.ajic.2016.01.003.
10. Lawley TD, Young VB. Murine models to study Clostridium difficileinfection and transmission. Anaerobe. 2013;24:94–97.
11. Buffie CG, Bucci V, Stein RR, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517:205–208.
12. Abt MC, Lewis BB, Caballero S, et al. Innate immune defenses mediated by two ilc subsets are critical for protection againstacute clostridium difficile infection. Cell Host Microbe.2015;18:27–37.
13. Lewis BB, Buffie CG, Carter RA, et al. Loss of microbiota-mediatedcolonization resistance to clostridium difficile infection with oralvancomycin compared with metronidazole. J Infect Dis.2015;212:1656–1665.
14. Vyas D, Aekka A, Vyas A. Fecal transplant policy and legislation. World J Gastroenterol. 2015;21:6–11.
15. Thom KA, Johnson JA, Strauss SM, et al. Increasing prevalence of gastrointestinal colonization with ceftazidime-resistant gram-negative bacteria among intensive care unit patients. Infect Control Hosp Epidemiol. 2007;28:1240–1246.
16. Safdar N, Bradley EA. The risk of infection after nasal colonizationwith Staphylococcus aureus. Am J Med. 2008;121:310–315.
17. Manning S, Lautenbach E, Tolomeo P, et al. Risk factors for infectionwith Escherichia coli in nursing home residents colonized with fluoroquinolone-resistant E. coli. Infect Control HospEpidemiol.2015;36:575–577.
18. Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis. 2002;34:441–446.
19. Kahvecioglu D, Ramiah K, McMaughan D, et al. Multidrug-resistant organism infections in US nursing homes: a national study of prevalence, onset, and transmission across care settings, October1, 2010-December 31, 2011. Infect Control HospEpidemiol. 2014;35:S48–S55.